Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024

▴ AVANTOR
Recognition reinforces Avantor's commitment to innovation and leadership for biopharma advancement.

SINGAPORE, Mar 21, 2024 - (ACN Newswire) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured five prestigious awards at the esteemed Asia-Pacific Biopharma Excellence Awards (ABEA) 2024. The ABEA event, held in conjunction with the 11th Annual Biologics Manufacturing Asia 2024, 8th BioLogistics World Asia 2024, and 2nd Annual Clinical Trials Festival Asia 2024, underscores Avantor’s exceptional achievements in bioprocessing, logistics, and supply chain management, as well as its leadership in the biopharma sector.

Avantor is honored with five ABEA awards, including three excellence recognitions and two individual accolades:

  • Overall Downstream Bioprocessing Supplier Award
  • Best Aseptic Fill-Finish and Packaging Supplier Award for Formulation Development
  • Best Bioprocessing Supplier Award for Single-use Systems
  • Bioprocessing Leadership Award presented to Narayana Rao, Vice President and General Manager, Bioscience Production, Asia Middle-East Africa (AMEA), Avantor
  • Supply Chain Management Lifetime Achievement Award conferred upon Yee Seng Ng, Vice President, Operations, Asia Middle-East Africa (AMEA), Avantor

Expressing gratitude for the recognition, Rao said, “We are honored to receive these awards, which represent our steadfast commitment to providing indispensable support to the biopharma industry across the AMEA region. I am proud of Avantor’s commitment to advancing manufacturing efficiency, cost-effectiveness, and quality while supporting our customers at every stage of their innovation lifecycle, from discovery to commercialization. I also would like to extend my sincere appreciation to Avantor for supporting the growth and development of our team.”

“These awards are a testament to the dedication and expertise of our Avantor team,” remarked Christophe Couturier, Executive Vice President of AMEA, Avantor. “At Avantor, we understand the critical importance of resilient and adaptable supply chains to enabling progress across the biopharma sector and we are committed to empowering our customers to optimize their bioprocessing operations.”

As a trusted global partner to the biopharma industry, Avantor supports customers across the AMEA region in navigating operational challenges such as productivity constraints providing unwavering support and driving innovation to accelerate life-changing innovation.

The Asia-Pacific Biopharma Excellence Awards (ABEA) recognizes exceptional Asian bioprocessing, biologistic, clinical trials and aseptic fill and finish experts, organizations and technologies. It celebrates outstanding achievements and innovations in the bioprocessing industry across the Asia Pacific region. The awards are judged by a panel of industry experts, and winners are selected based on their contributions to the advancement of the bioprocessing industry.

About Avantor®

Avantor®, a Fortune 500 company, is a leading life science tools company and global provider of mission-critical products and services to customers in the life sciences and advanced technology industries. From discovery to delivery, we work side-by-side with scientists around the world to enable breakthroughs in medicine, healthcare, and technology at scale. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026